Pacific Biosciences of California (PACB)

NASDAQ
23.56
+1.26(+5.65%)
After Hours
23.60
+0.04(+0.17%)
- Real-time Data
  • Volume:
    3,318,986
  • Bid/Ask:
    23.36/23.60
  • Day's Range:
    22.60 - 23.91

PACB Overview

Prev. Close
22.3
Day's Range
22.6 - 23.91
Revenue
92.3M
Open
22.61
52 wk Range
3.32 - 53.69
EPS
-0.41
Volume
3,318,986
Market Cap
4.67B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
3,980,899
P/E Ratio
-
Beta
1.19
1-Year Change
575.07%
Shares Outstanding
198,372,941
Next Earnings Date
Aug 05, 2021
What is your sentiment on Pacific Biosciences of California?
or
Market is currently closed. Voting is open during market hours.

Pacific Biosciences of California News

Pacific Biosciences of California Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralSellBuy
Technical IndicatorsSellBuyStrong BuyStrong SellStrong Buy
SummaryNeutralBuyBuyStrong SellStrong Buy

Pacific Biosciences of California Company Profile

Pacific Biosciences of California Company Profile

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Read More
  • ark Invest just bought a lot 250000 shares this week .go Cathy
    0
    • "Oh, think twice... it's just another -10% for you and me in paradise!"
      0
      • Adding more at sub 30. This is the stock will make me a millionaire in coming years
        1
        • go to the moon
          1
          • head over to BNGO
            9
            • Why? Becuase you own bahahahaha
              0
          • blow
            0
            • this is going to *****up
              0
              • Looks like Ark’s influence is stronger than softbank
                0
                • Sell and buy xoeng tomorrow earnings and this stock is too low . Tomorrow will go to the moon
                  1
                  • what is xoeng
                    0
                • revenue is bad and this is going up? LOL
                  1
                  • Softbank has invested here
                    0
                  • revenue is good enough concerning the cocid19
                    0
                • to the moon
                  0
                  • Big hands are moving the price today, look at the 5 minutes chart, first they raised it then they lowered it, difficult to understand where the final point of their strategy will be, hope ARK is not dropping massively the stock just before closing like they did with VCYT few weeks ago. VCYT is now 25% higher than where it was when they did it
                    0
                    • Hold and Buy . Good things to come!
                      0
                      • I'm -13% but I'm gonna hold.
                        0
                        • Buy & hold is the right way with this stock
                          0
                          • Praying God we have done with this red
                            0
                            • First green after 6 days. Hope it will remaing. Why this drop?
                              0
                          • anyone know why this is dropping hard?
                            0
                            • It seems to not only be specific to this stock but genomics and even wider than that.
                              0
                            • It's getting ready for bullrun chapter 2 of 2021
                              0
                          • Nice! I am in! For the long!
                            0
                            • Giorgios what do you think? How many stocks you have?
                              0
                              • just today to get all the sellers out and start flying
                                0
                                • Buy deep
                                  0
                                  • Are we in accumulation phase or i’m getting wrong?
                                    0
                                • Any idea about the merger date?
                                  0
                                  • Sorry, my bad. Wrong one
                                    0
                                • I like the bubble, bought cheaply
                                  0
                                  • Great buy opportunity today, PACB will probably skyrocket in 2021
                                    0
                                    • Gian Maria Malmesi ciao, ho scoperto quest'azione oggi e penso anch'io che abbia un bel potenziale. Tu sei dentro?
                                      0
                                    • Lore Trader  Ciao in a 22,54 , molto volatile ma segue l'onda delle disruptive technologies che rivoluzioneranno il futuro, biotech, EV e AI.
                                      0
                                  • The news about the biontech vaccine is said to be false.
                                    0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.